INTERNATIONAL PATENT: ALEXION PHARMACEUTICALS, INC. FILES APPLICATION FOR "TREATMENT OF MAYO STAGE IIIB LIGHT CHAIN AMYLOIDOSIS"

GENEVA, Sept. 22 -- ALEXION PHARMACEUTICALS, INC. (121 Seaport Blvd.Boston, MA 02210) filed a patent application (PCT/US2025/019922) for "TREATMENT OF MAYO STAGE IIIB LIGHT CHAIN AMYLOIDOSIS" on Mar 14, 2025. With publication no. WO/2025/194030, the details related to the patent application was published on Sep 18, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): SWENSON, Eugene Scott (121 Seaport Blvd.Boston, MA 02210)

Abstract: The disclosure is directed to methods of decreasing an amount of amyloid deposits in a subject with Mayo stage lllb light chain (AL) amyloidosis.

For more info...